Find an expert

Dr Craig Bell is an Industry Fellow with the Australian Institute for Bioengineering and Nanotechnology, and the Centre for Advanced Imaging. Since obtaining his PhD in 2011, he has been the recipient of two international fellowships, a prestigious Newton International Fellowship (2013-2014) funded by the Royal Society, and the NHMRC CJ Martin Early Career Fellowship (2014-2018). He has contributed scientific articles to various leading journals in his field, and is the co-inventor on two patents. His current research focus is on the development of degradable polymer devices for imaging and tracking of disease and cellular processes by using a tool-kit of controlled polymerisation techniques along with polymer and molecular coupling methodologies. The incorporation of degradable moieties into these constructs not only allows for enzymatic and hydrolytic degradation for complete body clearance of these constructs but also allows for tracking of these devices in vivo upon degradation to help elucidate cellular processes. Dr Bell currently engages with Aegros, a membrane fabrication and human serum fractionation company based in Sydney.

Professor Michael Monteiro has established an international reputation in the field of 'living' radical polymerization to create complex polymer architectures. He is now building designer polymers for various biomedical applications, including vaccines, drug delivery and stem cells. He is dedicated to translating research into commercial outcomes, with 7 PCT and provisional patents since 2005 and start-up company DendriMed Pty Ltd. He was awarded an ARC QEII Fellowship in 2004 and an ARC Future Fellowship in 2009. He has attracted ARC and NHMRC grants; and Queensland State Government funding in excess of $7 million.

International links

Professor Monteiro has built a strong collaboration with Professor Virgil Percec from the University of Pennsylvania to develop and understand the new SET-LRP. He has developed a collaboration with Professor Rachel O'Reilly from the University of Warwick to develop nanoreactors that mimic enzyme activity. In collaboration with Professor Eugenia Kumacheva from the University of Toronto, they developed temperature responsive micron-sized particles from encapsulation of cells.